From: Prenatal Virilization Associated with Paternal Testosterone Gel Therapy
Chronologic ageTwin A (months) | Ref.Range # | 0.1 | 12 | 18 | 22 | 23 | 25 | 29 | 34 | 38 |
---|---|---|---|---|---|---|---|---|---|---|
Total testosterone ng/dL(nM) | 3–10(0.07–0.4) | 9.8 (0.4) | 103(4) | 46 (1.8) | 129 (5.2) | 115 (4.8) | 217 (8.7) | 4.6 (0.18) | 13(0.5) | 2.3 (0.09) |
Androstenedione ng/dL (nM) | 10–17 (0.3–0.6) | 71 (2.0) | 64 (1.9) | 46 (1.4) |  |  | 55 (1.6) | 10 (0.03) |  |  |
17-Hydroxyprogesterone ng/dL (nM) | 3–90 (0.1–3) | 82 (2.4) | 17 (0.5) |  | 15 (0.45) | 14 (0.42) |  | 10 (0.3) |  |  |
17-Hyroxypregnenoloneng/dL (nM) | 14–207 (0.4–7) |  | 135 (4) |  |  |  |  |  |  |  |
Dehydroepiandrosterone ng/dL(nM) | 20–130 (0.6–4) |  | 20(0.6) |  | 47(1.4) | 83 (2.5) |  |  |  |  |
5-Dehydroepiandrosterone-sulfate mcg/dL | 5–57 |  |  | 11 |  |  | 10 | 22 |  |  |
(nM) | (0.1–1.4) |  |  | (0.44) |  |  | (0.4) | (0.88) |  |  |
Cortisol ng/dL (nM) | 3–21 (0.9–7) |  | 3(0.9) |  |  |  |  |  |  |  |
Renin ng/mL/hr(10) | 1–6.5 |  | 6.0 |  |  |  |  |  |  |  |
Estradiol ng/dL (nM) | 15 (0.4) | Â | Â | Â | 0.10 (0.003) | Â | Â | Â | Â | Â |
Deoxycorticosterone ng/dL (nM) | 2–34 (0.6–1.0) |  |  |  | 2.0 (0.06) |  |  |  |  |  |
DHT ng/dL(nM) | 3(0.3) | Â | Â | Â | Â | Â | 35(1.4) | Â | Â | Â |
Bone Age (mo) | Â | Â | 15 | 18 | 24 | Â | Â | Â | Â | 36 |